A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE2

Conditions

Hypertrophic Cardiomyopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing Municipality, China
Contact: Study coordinator (Lianming Kang) · lianmingkang@126.com · +86-010-88396870
Contact: Principal Investigator (Lianming Kang)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE3

Beijing, China

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE1, PHASE2

La Jolla, United States · San Francisco, United States

Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)

Cardiomyopathy

Abroad (travel likely)Recruiting

Minato-ku, Japan

Pediatric Cardiomyopathy Mutation Analysis

Cardiomyopathies · Dilated Cardiomyopathy · Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Indianapolis, United States